𝔖 Bobbio Scriptorium

✦ LIBER ✦

Single daily oral dose of gemfibrozil reduces postprandial hyperlipidemia in hyperlipidemic patients

✍ Scribed by Olivier Descamps; Jean-Claude Hondekijn; Thierry Godrie; Jean-Pierre Desager; Francis R. Heller

Book ID: 117091222
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 742 KB
Volume: 59
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(98)85094-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A test dose of I.V. busulfan (BU) is pre

A test dose of I.V. busulfan (BU) is predictive of the area under the curve (AUC) of a single daily dose of I.V. bu in pediatric patients undergoing a reduced intensity (RI) hematopoietic stem cell transplant (HSCT)

✍ M. Kletzel; D. Jacobsohn; R. Duerst 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 70 KB

1474 POSTER A phase I, open-label study

1474 POSTER A phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB